Alzheimer DiseaseAmyloid beta-Peptidestau ProteinsAmyloid beta-Protein PrecursorNeurofibrillary TanglesPlaque, AmyloidBrainApolipoprotein E4Amyloid Precursor Protein SecretasesDementiaPresenilin-1Cognition DisordersAmyloidAtrophyNeurofibrilsNeuropsychological TestsDementia, VascularMild Cognitive ImpairmentApolipoproteins EPresenilin-2Peptide FragmentsMental Status ScheduleHippocampusCognitionLewy Body DiseaseMagnetic Resonance ImagingAgingAge of OnsetMemantinePresenilinsAspartic Acid EndopeptidasesNeuronsAniline CompoundsCholinesterase InhibitorsMice, TransgenicNational Institute on Aging (U.S.)Memory DisordersSubstantia InnominataCerebral CortexCerebral Amyloid AngiopathyLongitudinal StudiesAutopsyBrain ChemistryAmyloidogenic ProteinsNerve DegenerationProtease NexinsDisease Models, AnimalDisease ProgressionPositron-Emission TomographyPhenylcarbamatesTauopathiesProdromal SymptomsNeurodegenerative DiseasesDown SyndromeIndansNootropic AgentsGenetic Predisposition to DiseaseLewy BodiesClioquinolThiazolesBiological MarkersFrontotemporal DementiaAmnesiaTemporal LobeNerve Tissue ProteinsGenotypeNeuropil ThreadsPsychomotor AgitationCase-Control StudiesTacrineCohort StudiesMemoryInsulysinChromosomes, Human, Pair 21Parkinson DiseaseReference ValuesPhosphorylationGalantamineMonomeric Clathrin Assembly ProteinsMutationApolipoprotein E2Kluver-Bucy SyndromeRisk FactorsAmyloidosisBenzothiazolesCaregiversFrontotemporal Lobar DegenerationGenetic TestingGlycogen Synthase Kinase 3NeurocalcinAllelesNerve Fibers, MyelinatedLDL-Receptor Related ProteinsCA2 Region, HippocampalSeverity of Illness IndexMolecular Sequence DataPostmortem ChangesModels, BiologicalMicrogliaCyclin-Dependent Kinase 5